TScan Therapeutics, Inc. (TCRX) stock
TCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/3089% below fair value
$0.15−0.00 (-1.72%)
Close on Nov 18, 2026Market cap $10.06MP/E –Yield –
TScan Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
TScan Therapeutics's market cap was $24.11M on Nov 11, 2026, against $141.55M a year earlier. Over the last 4 years it ranged from $11.02M to $710.03M, with a median of $140.22M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $24.11M | -81.1% |
| 2025 | Dec 31, 2025 | $127.52M | -60.3% |
| 2024 | Dec 31, 2024 | $320.92M | +15.7% |
| 2023 | Dec 29, 2023 | $277.42M | +879.4% |
| 2022 | Jan 31, 2022 | $28.33M | +7.3% |
| 2021 | Dec 31, 2021 | $26.39M | – |
See a number that looks wrong?